Lydia Pulido-Barrera

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Corrigendum to 'Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells'[Redox Biol 6(2015):174-182].

Corrigendum to 'Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells'[Redox Biol 6(2015):174-182].

Journal: Redox biology

Published: May 28, 2023

Correction: Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Correction: Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Journal: Gene therapy

Published: March 27, 2023

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial.

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial.

Journal: BMJ open

Published: September 28, 2021

Incidence and survival rate of de novo tumors in liver transplants.

Incidence and survival rate of de novo tumors in liver transplants.

Journal: Cirugia espanola

Published: December 21, 2017

1000 consecutive liver transplants. Descriptive analysis and evolution of a single center.

1000 consecutive liver transplants. Descriptive analysis and evolution of a single center.

Journal: Cirugia espanola

Published: April 09, 2017

Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.

Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.

Journal: Transplantation proceedings

Published: June 13, 2016

Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.

Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.

Journal: Redox biology

Published: August 01, 2015

Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells.

Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells.

Journal: Redox biology

Published: June 18, 2015

Is the sinusoidal obstructive syndrome post-liver transplantation a pathologic entity with a multifactorial etiology?

Is the sinusoidal obstructive syndrome post-liver transplantation a pathologic entity with a multifactorial etiology?

Journal: Revista espanola de enfermedades digestivas

Published: April 01, 2015

Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Journal: Gene therapy

Published: December 03, 2014

Modigraf administration through jejunostomy in liver transplant recipient: case report.

Modigraf administration through jejunostomy in liver transplant recipient: case report.

Journal: Transplantation proceedings

Published: December 10, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026